Zentek Announces Closing of Non-Brokered Private Placement of Units
Zentek Announces Closing of Non-Brokered Private Placement of Units
Guelph, ON – August 19, 2024, Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company is pleased to announce that it has closed its non-brokered private placement of units (the "Units") through the issuance of 2,361,500 Units at a price of $1.30 per Unit (the "Offering") for gross proceeds of $3,069,950. Net proceeds of the Offering will be used for working capital and general corporate purposes.
安大略省蓋爾夫——2024年8月19日,知識產權開發和商業化公司Zentek Ltd.(「Zentek」 或 「公司」)(納斯達克股票代碼:ZEN)欣然宣佈,它已通過以每單位1.30美元的價格發行2,361,500套(「本次發行」),完成了非經紀單位私募配售(「單位」),總收益爲每單位1.30美元(「本次發行」)爲3,069,950美元。本次發行的淨收益將用於營運資金和一般公司用途。
Zentek's CEO, Greg Fenton, commented: "We would like to thank all those who participated in the Offering. This funding will allow us to immediately allocate resources to our international market expansion strategy, where ZenGUARDTM-coated HVAC filters can play a meaningful role in an entity's sustainability objectives."
Zentek首席執行官格雷格·芬頓評論說:「我們要感謝所有參與此次發行的人。這筆資金將使我們能夠立即爲我們的國際市場擴張戰略分配資源,在該戰略中,ZenGuardtM塗層的HVAC過濾器可以在實體的可持續發展目標中發揮有意義的作用。」
Each Unit consists of one common share (each, a "Common Share") and one-half of one Common Share purchase warrant (each, a "Warrant"). Each whole Warrant entitles the holder thereof to purchase one Common Share at a price of $3.00 for a period of 24 months from the closing date of the Offering.
每個單位由一股普通股(每股均爲 「普通股」)和一半的普通股購買權證(均爲 「認股權證」)組成。每份完整認股權證的持有人有權在自發行截止之日起24個月內以3.00美元的價格購買一股普通股。
In connection with the closing of the Offering, the Company paid certain eligible persons a cash commission of $29,499.40 in the aggregate.
在本次發行結束時,公司向某些符合條件的人支付了總額爲29,499.40美元的現金佣金。
Closing of the Offering remains subject to receipt of all necessary corporate and regulatory approvals, including the approval of TSX Venture Exchange. All securities issued in connection with the Offering are subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.
本次發行的結束仍需獲得所有必要的公司和監管部門的批准,包括多倫多證券交易所風險交易所的批准。與本次發行有關的所有證券的持有期爲四個月加一天,持有期自發行之日起,並受適用證券立法的轉售規則約束。
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
本新聞稿不構成在美國出售任何證券的要約或招攬出售任何證券的要約。這些證券過去和將來都不會根據經修訂的1933年《美國證券法》(「美國證券法」)或任何州證券法進行註冊,除非根據美國《證券法》和適用的州證券法進行註冊或獲得此類註冊豁免,否則不得在美國境內或向美國個人發行或出售。
About Zentek Ltd.
關於 Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek是一家通過ISO 13485:2016 認證的知識產權技術公司,專注於新產品的研究、開發和商業化,旨在通過使公司的商業合作伙伴的產品更好、更安全、更環保,從而爲其商業合作伙伴提供競爭優勢。
Zentek's patented technology platform ZenGUARD, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD production facility is located in Guelph, Ontario.
Zentek的專利技術平台ZenGuard被證明具有99%的抗微生物活性,可顯著提高外科口罩的病毒過濾效率,其目標是對HVAC(供暖、通風和空調)系統起到同樣的作用。Zentek 的 ZenGuard 生產設施位於安大略省圭爾夫。
For further information on Zentek:
有關 Zentek 的更多信息:
investorrelations@zentek.com
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610
investorrelations@zentek.com
Ryan Shacklock
戰略與業務發展高級副總裁
電子郵件:rshacklock@zentek.com
電話:306-270-9610
To find out more about Zentek, please visit our website at . A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at .
要了解有關 Zentek 的更多信息,請訪問我們的網站。本新聞稿和與公司有關的所有重要文件的副本可在Zentek的SEDAR+個人資料上獲得,網址爲。
Forward-Looking Statements
前瞻性陳述
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
本新聞稿包含前瞻性陳述。由於前瞻性陳述涉及未來的事件和狀況,因此就其本質而言,它們涉及固有的風險和不確定性。儘管Zentek認爲在本新聞稿中準備前瞻性信息時使用的假設和因素是合理的,但不應過度依賴此類信息,這些信息僅適用於本新聞稿發佈之日,也無法保證此類事件會在披露的時間範圍內或根本不會發生。除法律要求外,Zentek不打算或有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
譯文內容由第三人軟體翻譯。